| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3818474 | La Presse Médicale | 2009 | 5 Pages |
Abstract
the absence of recommendations based on validated clinical trials evaluating the efficacy and safety of thrombembolism prophylactic treatment in palliative care patients lead to uncertain decisions for clinicians. Added to an objective evaluation of thrombotic and hemorrhagic risks factors, the wish of patient to receive or not active care is probably the most important element to consider.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Catherine Duverger, Bernard Tardy, Anne Richard, Thomas Célarier, Sophie Bayle, Marie Cambou, Jean Luc Perrot, Pascal Cathebras, Regis Gonthier,